Internal Medicine 1615 - Internal Medicine Alert - Aug 15, 2012

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/12. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Joseph E. Scherger, MD, MPH
Vice President, Primary Care
Eisenhower Medical Center;
Clinical Professor
Keck School of Medicine
University of Southern California

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

Rahul Gupta, MD, MPH, FACP
Clinical Assistant Professor,
West Virginia University School of Medicine
Charleston, WV

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor, Assistant Director
Family Practice Residency
Program, University of Florida

Subjects:

  • Might That Medrol Dosepak Trigger a Suicide?
  • Does Aortic Valve Calcification Predict Cardiovascular Events?
  • Studying the Issue of Off-label Prescribing in Primary Care
  • Pharmacology Update: Phentermine/Topiramate Extended-Release Capsules (Qsymia„¢ CIV)
  • Risk for Zoster from the Vaccine in Immunosuppressed Persons
  • Elucidating the'˜Best' Interval for Bone Density Screening in Osteoporosis
  • Cerebral Aneurysms: What's in Your Patient's Future?

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory board for Lilly, Boehringer Ingelheim, Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Lilly, Kowa, Novo Nordisk, and Teva.

Associate editors Joseph E. Scherger, MD, MPH, Harold L. Karpman, MD, FACC, FACP, Rahul Gupta, MD, MPH, FACP, William T. Elliott, MD, FACP, , and James Chan, PharmD, PhD, Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Associate editor Louis Kuritzky, MD is an advisor for Endo, Kowa, Pricara, and Takeda.

Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

Copyright 2012 AHC Media. All rights reserved.